Lilly says its once-daily insulin tops competitor’s drug
Eli Lilly & Co. said its experimental insulin helped diabetic patients more than Sanofi’s biggest product in studies that also raised some safety risks.
Bloomberg News
Articles
U.S. House votes to revive expired research tax credit
The 274-131 vote follows calls to restore the credit by a coalition of companies including Indianapolis-based Eli Lilly and Co. and Texas Instruments Inc.
UPDATE: Toyota to quit Camry production in Lafayette
Fuji Heavy Industries Ltd., the maker of Subaru cars, will stop making Camry cars in the U.S. for its largest shareholder, Toyota Motor Corp., in the second half of 2016. About 100,000 Camrys are made annually at the Indiana plant.
Bayer’s $14.2 billion Merck buy shows pharma strategy split
Bayer AG’s $14.2 billion acquisition of Merck & Co. is the latest in a series of big pharma deals and it exposes a deepening split in the way drugmakers approach their portfolios.
Insurers say most Obamacare enrollees paying premiums
Three large health insurers including Indianapolis-based WellPoint Inc. and Aetna Inc. say that a high percentage of their new Obamacare customers are paying their first premiums, partly undermining a Republican criticism of enrollment in the program.
Drug prices surge as generics, niche treatments eat profit
Since 2007, the cost of brand-name medicines has jumped, with prices doubling for dozens of established drugs that target everything from multiple sclerosis to cancer, blood pressure and even erections, according to an analysis conducted for Bloomberg News.
WellPoint shares rise after better-than-expected quarter
The Indianapolis-based health insurer increased its profit forecast after Obamacare enrollments boosted quarterly results.
Megadeals drive torrid pace for M&A activity
The value of corporate takeovers announced in 2014 hit the $1 trillion mark Monday, reaching that level at the fastest pace in seven years.
Seahawks’ Wilson overtakes Manning in NFL product sales
Former Colts quarterback Peyton Manning has been passed as the top National Football League player when it comes to merchandise sales. Two Colts rank among the top 50.
Lilly trade-secret defendants released to home detention
The court noted that after the government filed a second indictment March 12, the trade-secret theft claims against Guoqing Cao and Shuyu Li were changed to wire fraud, and aiding and abetting and conspiracy to commit wire fraud.
Former Pacers coach Jack Ramsay dies at 89
Jack Ramsay, who won an NBA title with Portland and coached the Indiana Pacers from 1986 to 1988, died Monday in Naples, Fla., after battling cancer for more than 15 years, ESPN reported
NCAA seeks to delay, split trial over use of player images
The lawsuit is part of a movement by current and former college athletes to secure compensation, and greater medical benefits, control over their images and labor protections in a system that considers them amateurs.
Zimmer shares hit 13-year high on Biomet deal
The deal will help Zimmer, a maker of artificial hips and knees, take on Johnson & Johnson, the No. 1 manufacturer in the now-growing $45 billion market.
Zimmer buying Biomet in $13.3B deal between Hoosier firms
Orthopedic device maker Zimmer Holdings Inc. is buying privately-held competitor Biomet Inc. in a cash-and-stock deal between the Warsaw-based companies valued at about $13.35 billion.
Lilly’s quarterly profit meets analyst expectations
The drugmaker, which is weathering patent expirations, saw sales fall more slowly than expected for its antidepressant Cymbalta.
Lilly wins approval for potential blockbuster drug
The Indianapolis-based pharmaceutical maker gets a much-needed boost with FDA approval for gastric-cancer drug ramucirumab, which quickly could account for $1 billion in annual sales.
Calumet may cut debt ratio without lower borrowings, CFO says
Indianapolis-based Calumet Specialty Products Partners LP plans to lower its leverage by increasing earnings rather than cutting debt that is rising by 35.6 percent this month.
Subaru awaiting Toyota’s decision about output in Indiana
Subaru, which added more U.S. market share than any international carmaker last year, is pushing ahead with U.S. expansion plans as it awaits a Toyota’s decision on whether it will keep building Camrys at Subaru’s Indiana plant.
Insurer acquires Indy-based StreetLinks for $60 million
StreetLinks, which sells real estate appraisal management services and software, will retain its brand name and remain headquartered in Indianapolis, according to the statement.
Pence gaining heavyweight support for 2016 presidential bid
Republicans are searching for a candidate who can unite the party’s pro-business establishment with its small-government activists. Pence’s allies say the temperate-toned governor has a record that pleases both.